The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...
The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...
Moderna shares fell more than 5% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine.
Investing.com -- Moderna (NASDAQ:MRNA) shares dropped 4.5% following reports that the Trump administration is considering withdrawing funding for the company’s bird flu vaccine. Bloomberg disclosed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果